Clinical Trial Update: A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for BMS-863233 in advanced and/or metastatic solid tumors (Phase 1/2) with terminated status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Cancers

Drugs mentioned

• BMS-863233

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Solid Cancers, Metastatic Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-04-28